Farhad Sheikh: Prasugrel vs Ticagrelor in Acute Coronary Syndromes
Farhad Sheikh, Medical Doctor at University of Tehran, shared a post on LinkedIn about a recent article by Elmir Omerovic et al., published in NEJM, adding:
“Among unselected patients undergoing PCI for an acute coronary syndrome, treatment under a default policy of prasugrel did not lead to a lower risk of a composite of death, myocardial infarction, or stroke at 1 year than treatment under a default policy of ticagrelor․”
Title: Prasugrel versus Ticagrelor in Acute Coronary Syndromes
Authors: Elmir Omerovic, Sasha Koul, Jonas Andersson, Johan Pontén, Fredrik Björklund, Robert Kastberg, Mila Sun, Charlotta Ljungman, Ole Fröbert, Kristian Bolin, Kristofer Skoglund, Carl-David Dolata, Mats Birgander, Helena Wikström, Truls Råmunddal, Oskar Angerås, Petur Petursson, David Erlinge, Björn Redfors

Stay updated with Hemostatis Today.
-
Nov 20, 2026, 05:02Jason Acker: Appointed as the Next Editor-in-Chief of Vox Sanguinis
-
Nov 20, 2026, 04:58Sabri Kemahli: International Society of Hematology Celebrates 80 Years of Hematology with Special Webinar
-
Nov 20, 2026, 04:46Alessandra Bosch: Swiss Haemophilia Network Wins Research Grant
-
Nov 20, 2026, 04:41Courtney Lawrence: HLA Antibodies and Platelet Transfusion Refractoriness in Hispanic Patients
-
Nov 20, 2026, 04:24Kamand Haeri: Platelet Function Testing by Flow Cytometry in Patients with BDUC at SOHC 2026
-
Nov 20, 2026, 00:33Overcoming Barriers to Diagnosis and Treatment for Women With Bleeding Disorders – EHC
-
Nov 20, 2026, 00:27Vera Stroikova: Key Takeaways on Electrophysiology and Stroke Prevention From the New Horizons 2026
-
Nov 20, 2026, 00:20Devi G. Nair Enrolls First US Patient in Smartphone Camera Atrial Fibrillation Detection Study
-
Nov 20, 2026, 00:14Saskia de Pee: Fortified Rice Cuts Anemia Risk by 57%